financetom
Business
financetom
/
Business
/
Workday to cut 1,750 jobs in AI push
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Workday to cut 1,750 jobs in AI push
Feb 5, 2025 5:09 AM

Feb 5 (Reuters) - Workday said on Wednesday it

will cut around 1,750 jobs, or 8.5% of its current workforce, as

the human capital management firm invests heavily in artificial

intelligence to counter a softer macroeconomic environment.

Shares of the California-based company jumped over 4% in

premarket trading.

Workday CEO Carl Eschenbach said the layoffs are necessary

to prioritize investments such as artificial intelligence, while

also freeing up resources to expand the company's presence in

different countries.

The layoffs come at a time when the human capital management

industry has grappled with slower spending by enterprise clients

as high interest rates have pressured tech budgets.

Workday expects to incur around $230 million to $270 million

in charges connected to the cost reduction plan, of which,

around $60 million to $70 million is expected to be recognized

in the fourth quarter.

As of Jan. 31 last year, the company had around 18,800

employees.

Workday faces stiff competition from other players in a

crowded industry as firms consolidate their position through

acquisitions to take market share.

Last month, Paychex ( PAYX ) said it will acquire Paycor

for $4.1 billion in cash, while Automatic Data

Processing ( ADP ) acquired management services provider

WorkForce Software for around $1.2 billion in cash in October.

Workday also said it expects its fiscal fourth quarter and

full-year financial results to be in-line with or above its

prior forecast.

The company forecast annual subscription revenue of $7.70

billion in November while it expects fourth-quarter subscription

revenue to be $2.03 billion - in line with analysts

expectations, as per data compiled by LSEG.

Workday also said it expects to close certain office spaces

that it owns and the actions associated with the cost reduction

plans should be completed by the second quarter of fiscal 2026.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
International, domestic insurers push into catastrophe-hit US property markets
International, domestic insurers push into catastrophe-hit US property markets
Dec 17, 2024
* Rising losses from natural disasters see some insurers cut cover in catastrophe-hit states * Homeowner premiums have soared, 50% rise not uncommon, broker says * Lloyd's of London insurance market has stepped in, has biggest market share (Adds comment from Allstate in paragraphs 4-5, updates dateline) By Carolyn Cohn and Noor Zainab Hussain LONDON, Dec 17 (Reuters) - International...
International, domestic insurers push into catastrophe-hit US property markets
International, domestic insurers push into catastrophe-hit US property markets
Dec 17, 2024
LONDON (Reuters) -International and domestic insurers are pushing into the U.S. market for hard-to-protect homes, charging high premiums and enjoying strong profits after some U.S. firms pulled out. Rising losses from storms, hurricanes and wildfires in recent years have caused some insurers, such as Allstate and State Farm, to cut back cover in catastrophe-hit states like Florida and California. This...
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
Dec 17, 2024
On Tuesday, Regeneron Pharmaceuticals, Inc. ( REGN ) announced the primary endpoint was met in the Phase 3 QUASAR trial investigating EYLEA HD (aflibercept) Injection 8 mg for the treatment of patients with macular edema following retinal vein occlusion (RVO) RVO is a blockage in one of the veins in the retina, the light-sensitive tissue at the back of the eye. Also...
--Tesla Accuses German Union of Sowing Unrest at Gigafactory, Reuters Reports
--Tesla Accuses German Union of Sowing Unrest at Gigafactory, Reuters Reports
Dec 17, 2024
01:05 PM EST, 12/17/2024 (MT Newswires) -- Price: 474.24, Change: +11.22, Percent Change: +2.42 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved